Found: 89
Select item for more details and to access through your institution.
Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 6, p. 1473, doi. 10.1093/cid/ciae043
- By:
- Publication type:
- Article
Imipenem/relebactam pharmacokinetics in critically ill patients supported on extracorporeal membrane oxygenation.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 5, p. 1118, doi. 10.1093/jac/dkae079
- By:
- Publication type:
- Article
Response to comment on "International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists"
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 2, p. 208, doi. 10.1002/phar.2907
- By:
- Publication type:
- Article
Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
- Published in:
- American Journal of Health-System Pharmacy, 2024, v. 81, n. 1, p. e21, doi. 10.1093/ajhp/zxad232
- By:
- Publication type:
- Article
International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 8, p. 736, doi. 10.1002/phar.2844
- By:
- Publication type:
- Article
International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 8, p. 740, doi. 10.1002/phar.2842
- By:
- Publication type:
- Article
A Retrospective Case Series of Concomitant Carbapenem and Valproic Acid Use: Are Best Practice Advisories Working?
- Published in:
- Journal of Pharmacy Practice, 2023, v. 36, n. 3, p. 537, doi. 10.1177/08971900211063301
- By:
- Publication type:
- Article
Bronchopulmonary disposition of IV cefepime/taniborbactam (2–0.5 g) administered over 2 h in healthy adult subjects.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 3, p. 703, doi. 10.1093/jac/dkac447
- By:
- Publication type:
- Article
Imipenem/cilastatin/relebactam pharmacokinetics in critically ill patients with augmented renal clearance.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 11, p. 2992, doi. 10.1093/jac/dkac261
- By:
- Publication type:
- Article
Trimethoprim/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 11, p. 3187, doi. 10.1093/jac/dkac304
- By:
- Publication type:
- Article
Impact of a Pharmacist-Managed Procalcitonin Program on COVID-19 Respiratory Tract Infection Outcomes and Health Care Resource Utilization.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 9, p. 1, doi. 10.1093/ofid/ofac468
- By:
- Publication type:
- Article
Antimicrobial Stewardship at Transitions of Care to Outpatient Settings: Synopsis and Strategies.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 8, p. N.PAG, doi. 10.3390/antibiotics11081027
- By:
- Publication type:
- Article
Impact of Order-Set Modifications and Provider Education Following Guideline Updates on Broad-Spectrum Antibiotic Use in Patients Admitted With Community Acquired Pneumonia.
- Published in:
- Hospital Pharmacy, 2022, v. 57, n. 4, p. 496, doi. 10.1177/00185787211055797
- By:
- Publication type:
- Article
Omadacycline pharmacokinetics and soft-tissue penetration in diabetic patients with wound infections and healthy volunteers using in vivo microdialysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Minocycline pharmacodynamics against Stenotrophomonas maltophilia in the neutropenic murine infection model: implications for susceptibility breakpoints.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pharmacodynamic Thresholds for Beta-Lactam Antibiotics: A Story of Mouse Versus Man.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.833189
- By:
- Publication type:
- Article
Levofloxacin pharmacodynamics against Stenotrophomonas maltophilia in a neutropenic murine thigh infection model: implications for susceptibility breakpoint revision.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A guide to therapeutic drug monitoring of β‐lactam antibiotics.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 2, p. 220, doi. 10.1002/phar.2505
- By:
- Publication type:
- Article
Contemporary analysis of ETEST for antibiotic susceptibility and minimum inhibitory concentration agreement against Pseudomonas aeruginosa from patients with cystic fibrosis.
- Published in:
- Annals of Clinical Microbiology & Antimicrobials, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12941-021-00415-0
- By:
- Publication type:
- Article
Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumonia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Development of Daptomycin Susceptibility Breakpoints for Enterococcus faecium and Revision of the Breakpoints for Other Enterococcal Species by the Clinical and Laboratory Standards Institute.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 6, p. 1240, doi. 10.1093/cid/ciz845
- By:
- Publication type:
- Article
Monte Carlo Simulation Methodologies for β‐Lactam/β‐Lactamase Inhibitor Combinations: Effect on Probability of Target Attainment Assessments.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 2, p. 172, doi. 10.1002/jcph.1510
- By:
- Publication type:
- Article
Reply to Cheng and Chuang.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Evaluation of Plazomicin, Tigecycline, and Meropenem Pharmacodynamic Exposure against Carbapenem-Resistant Enterobacteriaceae in Patients with Bloodstream Infection or Hospital-Acquired/Ventilator-Associated Pneumonia from the CARE Study (ACHN-490-007).
- Published in:
- Infectious Diseases & Therapy, 2019, v. 8, n. 3, p. 383, doi. 10.1007/s40121-019-0251-4
- By:
- Publication type:
- Article
Critique of prevention of pneumococcal disease in high risk adults: A pharmacist‐based assessment of adult immunization protocols in clinical practice.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Pharmacodynamic Analysis of Daptomycin-treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 10, p. 1650, doi. 10.1093/cid/ciy749
- By:
- Publication type:
- Article
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
- Published in:
- American Journal of Health-System Pharmacy, 2018, v. 75, n. 14, p. 1048, doi. 10.2146/ajhp170839
- By:
- Publication type:
- Article
Defining the potency of amikacin against <em>Escherichia coli</em>, <em>Klebsiella pneumoniae</em>, <em>Pseudomonas aeruginosa</em>, and <em>Acinetobacter baumannii</em> derived from Chinese hospitals using CLSI and inhalation-based breakpoints.
- Published in:
- Infection & Drug Resistance, 2018, v. 11, p. 783, doi. 10.2147/IDR.S161636
- By:
- Publication type:
- Article
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
- Published in:
- American Journal of Health-System Pharmacy, 2018, v. 75, n. 1, p. e36, doi. 10.2146/ajhp170123
- By:
- Publication type:
- Article
Simplifying Piperacillin/Tazobactam Dosing: Pharmacodynamics of Utilizing Only 4.5 or 3.375 g Doses for Patients With Normal and Impaired Renal Function.
- Published in:
- Journal of Pharmacy Practice, 2017, v. 30, n. 6, p. 593, doi. 10.1177/0897190016684453
- By:
- Publication type:
- Article
Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 6, p. 712, doi. 10.1002/jcph.851
- By:
- Publication type:
- Article
Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration.
- Published in:
- American Journal of Health-System Pharmacy, 2017, v. 74, n. 1, p. e55, doi. 10.2146/ajhp150733
- By:
- Publication type:
- Article
Population pharmacokinetics of meropenem administered as a prolonged infusion in children with cystic fibrosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Vancomycin serum concentrations do not adequately predict tissue exposure in diabetic patients with mild to moderate limb infections.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 7, p. 2064, doi. 10.1093/jac/dkv074
- By:
- Publication type:
- Article
Population pharmacokinetics of the piperacillin component of piperacillin/tazobactam in pediatric oncology patients with fever and neutropenia.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 3, p. 477, doi. 10.1002/pbc.25287
- By:
- Publication type:
- Article
Impact of Loading Doses on the Time to Adequate Predicted Beta-Lactam Concentrations in Prolonged and Continuous Infusion Dosing Schemes.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and –20 °C.
- Published in:
- American Journal of Health-System Pharmacy, 2014, v. 71, n. 17, p. 1480, doi. 10.2146/ajhp130664
- By:
- Publication type:
- Article
In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 10, p. 2296
- By:
- Publication type:
- Article
Pharmacokinetics of Doripenem in Infected Patients Treated Within and Outside the Intensive Care Unit.
- Published in:
- Annals of Pharmacotherapy, 2013, v. 47, n. 5, p. 617, doi. 10.1345/aph.1R789
- By:
- Publication type:
- Article
Comparative Pharmacokinetics, Pharmacodynamics, and Tolerability of Ertapenem 1 Gram/Day Administered as a Rapid 5-Minute Infusion versus the Standard 30-Minute Infusion in Healthy Adult Volunteers.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 3, p. 266, doi. 10.1002/phar.1197
- By:
- Publication type:
- Article
Pharmacokinetics and Monte Carlo Simulations of Doripenem in Patients with Febrile Neutropenia.
- Published in:
- Annals of Pharmacotherapy, 2012, v. 46, n. 10, p. 1281, doi. 10.1345/aph.1R097
- By:
- Publication type:
- Article
Inappropriate Antibiotic Use Due to Decreased Compliance with a Ventilator-Associated Pneumonia Computerized Clinical Pathway: Implications for Continuing Education and Prospective Feedback.
- Published in:
- Pharmacotherapy, 2012, v. 32, n. 8, p. 755, doi. 10.1002/j.1875-9114.2012.01161.x
- By:
- Publication type:
- Article
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration.
- Published in:
- American Journal of Health-System Pharmacy, 2011, v. 68, n. 23, p. 2265, doi. 10.2146/ajhp100663
- By:
- Publication type:
- Article
Pharmacodynamic evaluation of i.v. antimicrobials against Pseudomonas aeruginosa samples collected from U.S. hospitals.
- Published in:
- American Journal of Health-System Pharmacy, 2011, v. 68, n. 17, p. 1619, doi. 10.2146/ajhp100569
- By:
- Publication type:
- Article
Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States.
- Published in:
- Mycoses, 2011, v. 54, n. 5, p. e301, doi. 10.1111/j.1439-0507.2010.01903.x
- By:
- Publication type:
- Article
Optimization of meropenem dosage in the critically ill population based on renal function.
- Published in:
- Intensive Care Medicine, 2011, v. 37, n. 4, p. 632, doi. 10.1007/s00134-010-2105-0
- By:
- Publication type:
- Article
Ceftaroline: A novel cephalosporin with methicillin-resistant Staphylococcus aureus and multidrug-resistant Streptococcus pneumoniae activity.
- Published in:
- Formulary, 2011, v. 46, n. 3, p. 71
- By:
- Publication type:
- Article